Herbalife (HLF) Valuation Check After Recent Share Price Volatility

Herbalife (HLF) is back on investors' radar after recent share price pressure, with the stock showing a 25.2% decline over the past month following an earlier 8.1% gain in the past 3 months.

See our latest analysis for Herbalife.

At a share price of $14.41, Herbalife’s recent 1 month share price return of a 25.2% decline contrasts with a 12.4% year to date share price gain and a 68.14% 1 year total shareholder return. This suggests that momentum has recently faded after a stronger run.

If this kind of volatility has you looking at other opportunities, it could be a useful moment to scan 20 top founder-led companies

With Herbalife trading at $14.41 and indicators like a value score of 5 and a 53.48% intrinsic discount estimate, the key question is whether the recent pullback offers a buying window or if the market already reflects future growth.

Most Popular Narrative: 2.9% Overvalued

Herbalife's fair value in the most widely followed narrative sits at $14, slightly below the last close of $14.41, which frames the current pullback in a tight valuation range.

The analyst price target on Herbalife in our model has moved from US$12 to US$14, as analysts point to a recovery path supported by a healthier profit margin outlook, a slightly lower discount rate, and recent research highlighting ongoing business model improvements despite tempered revenue growth expectations and cautious sector valuations.

Read the complete narrative.

Curious what sits behind that fair value move, even as growth assumptions stay restrained and the discount rate barely shifts? The narrative leans heavily on margins, earnings power and how much investors might be willing to pay for those future profits.

Result: Fair Value of $14 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, that margin focused story could be upended if regulatory scrutiny of multi level marketing models intensifies, or if consumer demand shifts further toward whole foods over supplements.

Find out about the key risks to this Herbalife narrative.

Another View on Herbalife’s Valuation

The first narrative pegs Herbalife around fair value at $14 using earnings power and margins. Yet current checks show the shares trading on a P/E of 6.5x versus a peer average of 69.9x and a fair ratio of 13.8x. That kind of gap hints at valuation risk, but also raises the question: what is the market still unsure about?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Mixed messages in the data so far? If that leaves you on the fence, move quickly, review both sides of the story, and weigh the 3 key rewards and 2 important warning signs.

Ready for more investment ideas?

If Herbalife has you rethinking your watchlist, do not stop here, use this momentum to scout other stocks that might better fit your goals.

• Target resilient cash generators with strong fundamentals by scanning the solid balance sheet and fundamentals stocks screener (39 results).
• Hunt for potential mispriced opportunities by reviewing the 61 high quality undervalued stocks.
• Lock in ideas for income focused portfolios by checking out the 12 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com